Mitochondrial stress response triggered by defects in protein synthesis quality control

Area of Science:

• Cell Biology
• Mitochondrial Biology
• Molecular Medicine

Background:

• Mitochondria possess a unique gene expression system for synthesizing essential oxidative phosphorylation proteins.
• Quality control mechanisms are crucial to prevent aberrant protein synthesis from disrupting mitochondrial function.
• Pathogenic mutations in the AFG3L2/paraplegin protease complex lead to severe clinical syndromes and cellular defects.

Purpose of the Study:

• To elucidate the molecular etiology of phenotypes associated with AFG3L2/paraplegin mutations.
• To understand the stress response triggered by impaired mitochondrial protein synthesis quality control.
• To investigate the potential of modulating mitochondrial protein synthesis for therapeutic benefit.

Main Methods:

• Investigated the cellular and molecular consequences of AFG3L2/paraplegin complex dysfunction.
• Analyzed the sequential stress response involving OMA1 activation, ribosome loss, and inner membrane remodeling.
• Utilized chloramphenicol to inhibit mitochondrial protein synthesis and assess its impact on the stress response.

Main Results:

• Disruptions in mitochondrial protein synthesis quality control initiate a stress cascade.
• This cascade involves OMA1 activation, mitochondrial ribosome loss, and altered inner membrane structure.
• Inhibition of mitochondrial protein synthesis effectively blocked this pathological stress response.

Conclusions:

• Established a mechanistic link between AFG3L2 pathogenesis and observed cellular phenotypes.
• Demonstrated that impaired mitochondrial protein synthesis quality control triggers a specific stress response.
• Showed that modulating mitochondrial protein synthesis can restore organelle homeostasis and offers a potential therapeutic avenue.